Company / Current Liabilities
Vaxcyte, Inc. Current Liabilities History
FY2019-FY2025 · Annual data · Source: SEC filings
At a glance
Latest annual filing availableLatest Current Liabilities
$205.8M
FY2025
5-year range
$28.7M / $205.8M
FY2021-FY2025
Trend
+46.8%
vs FY2024
Sector context
#58 of 213
Health Care
What the data says
At $206M, Vaxcyte, Inc.'s current liabilities ranks #156 of 213 in the Health Care sector. Current Liabilities has fluctuated over the past 7 years, ranging from $11M in FY2019 to $206M in FY2025.
Based on SEC 10-K filings.
$206M in FY2025 with a 5-year CAGR of +34.4%.
Increased from $145M to $206M over the past 2 years.
Health Care sector context is included.
Current Liabilities over time
Growth rates
- 3-Year CAGR
- +71.9%
- 5-Year CAGR
- +34.4%
- 10-Year CAGR
- -
Sector benchmark
#156 of 213 in Health CareTop 73% of 213This company $205.8M Sector average $1.6B
▼
-87.0% below sector average
Key checks
Key Insights
- 5-year CAGR of +34.4%, indicating consistent growth.
- In FY2025, current liabilities increased 46.8% year-over-year.
- Ranks #58 out of 213 companies in the Health Care sector.
- Lowest current liabilities in the period was in FY2019.
Company context
Key Data Points
- Low Piotroski F-Score: 1/9 (multiple financial health concerns)
- Altman Z-Score 2.94 (safe zone, above 2.9 threshold)
- High earnings quality (cash-backed earnings)
Data sourced from SEC EDGAR filings. Not investment advice.
Annual data
| Year | Current LiabilitiesValue | YoY GrowthYoY |
|---|---|---|
| FY2025 | $205.8M | +46.8% |
| FY2024 | $140.2M | -3.5% |
| FY2023 | $145.3M | +258.6% |
| FY2022 | $40.5M | +41.1% |
| FY2021 | $28.7M | -38.7% |
| FY2020 | $46.9M | +324.0% |
| FY2019 | $11.1M | - |
| FY2018 | - | - |
As of FY2025 · SEC 10-K · Updated Feb 28, 2026